Works matching IS 13406868 AND DT 2021 AND VI 28 AND IP 5


Results: 18
    1
    2
    3
    4
    5
    6
    7
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy.

    Published in:
    Breast Cancer (13406868), 2021, v. 28, n. 5, p. 1038, doi. 10.1007/s12282-021-01239-8
    By:
    • Inoue, Kenichi;
    • Masuda, Norikazu;
    • Iwata, Hiroji;
    • Takahashi, Masato;
    • Ito, Yoshinori;
    • Miyoshi, Yasuo;
    • Nakayama, Takahiro;
    • Mukai, Hirofumi;
    • van der Walt, Jan-Stefan;
    • Mori, Joji;
    • Sakaguchi, Sachi;
    • Kawaguchi, Tsutomu;
    • Tanizawa, Yoshinori;
    • Llombart-Cussac, Antonio;
    • Sledge Jr, George W.;
    • Toi, Masakazu
    Publication type:
    Article
    18

    Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study).

    Published in:
    Breast Cancer (13406868), 2021, v. 28, n. 5, p. 1023, doi. 10.1007/s12282-021-01238-9
    By:
    • Futamura, Manabu;
    • Oba, Mari;
    • Masuda, Norikazu;
    • Bando, Hiroko;
    • Okada, Morihito;
    • Yamamoto, Yutaka;
    • Kin, Takanori;
    • Saeki, Toshiaki;
    • Nagashima, Takeshi;
    • Kuwayama, Takashi;
    • Toh, Uhi;
    • Hirano, Akira;
    • Inokuchi, Masafumi;
    • Yamagami, Kazuhiko;
    • Mizuno, Yutaka;
    • Kojima, Yasuyuki;
    • Nakayama, Takahiro;
    • Yasojima, Hiroyuki;
    • Ohno, Shinji
    Publication type:
    Article